【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 API Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Growing prevalence of target diseases such as hospital acquired infections, genetic, cardiovascular and neurological diseases
3.1.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.1.1.4 Increasing preference for outsourcing APIs
3.1.2 Market restraint analysis
3.1.2.1 Large capital investments and production cost
3.1.3 Stringent safety and handling regulations regarding APIs
3.2 Penetration & growth prospect mapping
3.3 Active Pharmaceutical Ingredient – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 API Market: Type of Synthesis Estimates & Trend Analysis
4.1 Active pharmaceutical ingredient market: Type of synthesis movement analysis
4.2 Biotech
4.2.1 Biotech market, 2014 – 2025 (USD Billion)
4.2.2 Monoclonal Antibodies
4.2.3 Monoclonal Antibodies market, 2014 – 2025 (USD Billion)
4.2.4 Recombinant proteins
4.2.5 Recombinant proteins market, 2014 – 2025 (USD Billion)
4.2.6 Vaccines
4.2.7 Vaccines market, 2014 – 2025 (USD Billion)
4.3 Synthetic
4.3.1 Synthetic market, 2014 – 2025 (USD Billion)
Chapter 5 API Market: Type of Manufacturer Estimates & Trend Analysis
5.1 Active pharmaceutical ingredient market: Type of Manufacturer movement analysis
5.2 Captive APIs
5.2.1 Captive APIs market, 2014 – 2025 (USD Billion)
5.3 Merchant APIs
5.3.1 Merchant APIs market, 2014 – 2025 (USD Billion)
Chapter 6 API Market: Type Estimates & Trend Analysis
6.1 Active pharmaceutical ingredient market: Type movement analysis
6.2 Generic APIs
6.2.1 Generic APIs market, 2014 – 2025 (USD Billion)
6.3 Innovative APIs
6.3.1 Innovative APIs market, 2014 – 2025 (USD Billion)
Chapter 7 API Market: Application Estimates & Trend Analysis
7.1 Active pharmaceutical ingredient market: Application movement analysis
7.2 Cardiovascular Disease
7.2.1 Cardiovascular Disease market, 2014 – 2025 (USD Billion)
7.3 Oncology
7.3.1 Oncology market, 2014 – 2025 (USD Billion)
7.4 CNS and Neurological Disorders
7.4.1 CNS and Neurological Disorders market, 2014 – 2025 (USD Billion)
7.5 Orthopedic Disorders
7.5.1 Orthopedic Disorders market, 2014 – 2025 (USD Billion)
7.6 Endocrinology
7.6.1 Endocrinology market, 2014 – 2025 (USD Billion)
7.7 Pulmonology
7.7.1 Pulmonology market, 2014 – 2025 (USD Billion)
7.8 Gastrointestinal Disorders
7.8.1 Gastrointestinal Disorders market, 2014 – 2025 (USD Billion)
7.9 Nephrology
7.9.1 Nephrology market, 2014 – 2025 (USD Billion)
7.10 Ophthalmology
7.10.1 Ophthalmology market, 2014 – 2025 (USD Billion)
7.10.2 Others market, 2014 – 2025 (USD Billion)
Chapter 8 API Market: Regional Estimates & Trend Analysis
8.1 Active pharmaceutical ingredient market share, by region, 2015 & 2025
8.2 North America
8.2.1 North America active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.2.2 U.S
8.2.2.1 U.S active pharmaceutical Ingredient market, 2014 – 2025 (USD Billion)
8.2.3 Canada
8.2.3.1 Canada active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3 Europe
8.3.1 Europe active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3.2 UK
8.3.2.1 UK active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3.3 Germany
8.3.3.1 Germany active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.2 Japan
8.4.2.1 Japan active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.3 China
8.4.3.1 China active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.4 India
8.4.4.1 India active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5.2 Brazil
8.5.2.1 Brazil active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5.3 Mexico
8.5.3.1 Mexico active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.6 MEA
8.6.1 MEA active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.6.2 South Africa
8.6.2.1 South Africa active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 AbbVie, Inc.
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Boehringer Ingelheim GmbH
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Bristol-Myers Squibb Company
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 Cipla, Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Merck& Co., Inc.
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Albemarle Corporation
9.3.6.1 Company overview
9.3.6.2 Financial overview
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Aurobindo Pharma
9.3.7.1 Company overview
9.3.7.2 Financial overview
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Mylan N.V.
9.3.8.1 Company overview
9.3.8.2 Financial overview
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Teva Active Pharmaceuticals Industries Ltd.
9.3.9.1 Company overview
9.3.9.2 Financial overview
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Sun Pharmaceutical Industries, Ltd.
9.3.10.1 Company overview
9.3.10.2 Financial overview
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Dr. Reddy’s Laboratories Ltd
9.3.11.1 Company overview
9.3.11.2 Financial overview
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
【レポート販売概要】
■ タイトル：医薬品有効成分（API）の世界市場規模及び予測：合成別（バイオ技術、合成）、メーカー種類別（キャプティブ、マーチャント）、種類別（一般、革新的）、用途別、動向分析 2014-2025■ 英文：Active Pharmaceutical Ingredients (API) Market Size And Forecast By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type (Generic, Innovative), By Application And Trend Analysis, 2014-2025
■ 発行日：2017年1月2日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707013
■ 調査対象地域：グローバル
- ブルドーザーの世界市場2015-2019About bulldozer tractor A bulldozer is a type of crawler with an attached blade that is used to dig or move large quantities of soil, sand, and other construction materials in construction sites. The blade is typically equipped on the rear end with a ripper, shaped as a claw, that helps in loosening densely compacted materials. Various types of bulldozers operate in almost all types of infrastruct …
- ホットメルト接着剤の世界市場2016-2020About the Hot Melt Adhesives Market Hot melt adhesives are solvent-free thermoplastic materials. They are molten at temperatures ranging from 248°F to 356°F and used as an adhesive. Unlike solvent-based or water-based adhesives, these adhesives do not require curing or drying. They solidify in a short time span and form a strong bond with an extensive range of substrates. Technavio’s analysts fore …
- 提案管理ソフトウェアの世界市場予測：ソフトウェア別、サービス別、展開種類別、組織規模別Increasing shift to cloud-based technologies is driving the proposal management softwareMarketsandMarkets projects the global proposal management software market size to grow from USD 1.5 billion in 2019 to USD 3.1 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 14.9% during the forecast period. Major factors expected to drive the growth of the proposal management software market inclu …
- 過敏性腸症候群(Irritable Bowel Syndrome)：世界の治験レビュー（2015年上半期版）Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Irritable Bowel Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Irritable Bowel Syndrome. It includes an overview of the trial num …
- 電子化学薬品及び材料の世界市場予測：特殊ガス、CMPスラリー、導電性ポリマー、フォトレジストケミカル、低K誘電体、ウェットケミカル、シリコンウェーハ、PCBラミネート“The increasing demand from microelectronic and chip manufacturing companies is expected to drive the market.”The electronic chemicals and materials market size is projected to grow from USD 56.3 billion in 2019 to USD 81.6 billion by 2024, at a compound annual growth rate (CAGR) of 7.7% during the forecast period. The market is driven by the growth of the microelectronics industry, which is chara …
- コバルトの世界市場動向2014/2015The report presents a thorough study of cobalt, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing cobalt worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: cobalt production in the country, major manufacturers …
- 急性冠症候群（Acute Coronary Syndrome）の治療薬開発：グローバル製薬企業動向PharmaPoint: Acute Coronary Syndrome - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Acute Coronary Syndrome - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing ACS Market. The report identifies and analyses the key companies shaping and driving the global …
- ITトレーニングの世界市場2015-2019About IT Training IT training refers to the professional training offered by universities, enterprises, and non-formal professional institutes that comprise of B2C (business-to-consumer), B2G (business-to-government), and B2B (business-to-business) training. More number of institution have begun to offer informal and social learning platforms to teach IT, which has changed the learning landscape o …
- 先進バイポ—ラ・ダイレクト・エネルギー・デバイスの世界市場：電気外科用発電機、バイポ—ラ電気外科デバイスTechnavio’s research analyst predicts the global advanced bipolar direct energy devices market to grow steadily at an impressive CAGR of more than 14% by 2020. The ability of bipolar direct energy devices to enhance patients’ safety by reducing the collateral damage to the surrounding tissue is an important factor that bolsters its adoption during the forecast period. The inexpensive nature and re …
- 口腔粘膜炎：グローバル臨床試験レビュー（2014年上半期）Oral Mucositis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Oral Mucositis Global Clinical Trials Review, H1, 2014" provides data on the Oral Mucositis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oral Mucositis. It includes an overview of the trial numbers and their recruitment status as per …
- 工場資産管理システムの世界市場2016-2020About Plant Asset Management System A PAM system manages and monitors the fixed assets of a company, which are used in the production process. PAM gives a better control over the production process and generates a real-time data of assets, which enables officials to take informed decision. The real-time data generated by a PAM system can also be used to identify signs of failure, ensuring that pla …
- 小児がん(Pediatric Cancer)：世界の治験レビュー（2015年上半期版）Pediatric Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, H1, 2015" provides data on the Pediatric Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pediatric Cancer. It includes an overview of the trial numbers and their recruitment statu …
- 金属製押出しチューブの世界市場展望2017-2026According to Stratistics MRC, the Global Collapsible Metal Tubes is accounted for $1,065.78 million in 2017 and is expected to reach $1,625.24 million by 2026 growing at a CAGR of 4.8% during the forecast period. Growing demand for the cosmetic and personal care product, the superior barrier traits of collapsible metal tubes, high demand for private label brands and various expansion activities by …
- Activa Resources AG：石油・ガスバリューチェーン分析レポート2013Activa Resources AG Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Activa Resources AG" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Activa Resources AG”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- Vaginal Cancer：グローバル臨床試験レビューH2, 2013Vaginal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Vaginal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vaginal Cancer. It includes an overview of the trial numbers and their recruitment status as per …
